Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of AZD0780 in Participants With Dyslipidaemia [Phase 2, Phase 3]

View source ↗

Summary

An ongoing Phase 2/Phase 3 study evaluating the efficacy, safety, and pharmacokinetics of AZD0780 in participants with dyslipidaemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidaemia

Drugs mentioned

• AZD0780

Snippet

Sponsor: AstraZeneca | Conditions: Dyslipidaemia | Phase 2, Phase 3 | Status: RECRUITING